{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:06:38Z","timestamp":1794013598636,"version":"4.8.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0614"],"award-info":[{"award-number":["2022YFS0614"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0622"],"award-info":[{"award-number":["2022YFS0622"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023NSFSC0620"],"award-info":[{"award-number":["2023NSFSC0620"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.actbio.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T07:31:23Z","timestamp":1726212683000},"page":"27-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy"],"prefix":"10.1016","volume":"188","author":[{"given":"Jiang","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojin","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-2450","authenticated-orcid":false,"given":"Meiling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.molmed.2022.05.004","article-title":"Antibody signatures in inflammatory bowel disease: current developments and future applications","volume":"28","author":"Bourgonje","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.actbio.2024.09.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.actbio.2024.09.007_bib0003","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijbiomac.2020.09.214","article-title":"Natural proteins and polysaccharides in the development of micro\/nano delivery systems for the treatment of inflammatory bowel disease","volume":"165","author":"Shah","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40168-022-01275-2","article-title":"Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis","volume":"10","author":"Sinha","year":"2022","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"issue":"10114","key":"10.1016\/j.actbio.2024.09.007_bib0006","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0007","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10717544.2016.1245367","article-title":"Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease","volume":"24","author":"Qiao","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2024.09.007_bib0008","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-0-12-391860-4.00019-7","article-title":"Polymeric nanoparticles for the selective therapy of inflammatory bowel disease","volume":"508","author":"Wachsmann","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0009","doi-asserted-by":"crossref","unstructured":"T. Hammer, S.N. Lophaven, K.R. Nielsen, M.S. Petersen, P. Munkholm, P. Weihe, J. Burisch, E. Lynge, Dietary risk factors for inflammatory bowel diseases in a high-risk population: results from the Faroese IBD study, United Eur. Gastroenterol. J. 2019;7(7):924\u2013932.","DOI":"10.1177\/2050640619852244"},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fmed.2014.00003","article-title":"New strategies for treatment of inflammatory bowel disease","volume":"1","author":"Nielsen","year":"2014","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"issue":"18","key":"10.1016\/j.actbio.2024.09.007_bib0013","doi-asserted-by":"crossref","first-page":"eaaz2630","DOI":"10.1126\/sciadv.aaz2630","article-title":"Graphene quantum dots as anti-inflammatory therapy for colitis","volume":"6","author":"Lee","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2024.09.007_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.07.012","article-title":"Micro and nanoscale technologies in oral drug delivery","volume":"157","author":"Ahadian","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"48","key":"10.1016\/j.actbio.2024.09.007_bib0015","doi-asserted-by":"crossref","first-page":"eabi9265","DOI":"10.1126\/sciadv.abi9265","article-title":"Orally deliverable strategy based on microalgal biomass for intestinal disease treatment","volume":"7","author":"Zhong","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0016","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1021\/acsnano.0c01018","article-title":"Nanoparticles derived from the natural antioxidant rosmarinic acid ameliorate acute inflammatory bowel disease","volume":"14","author":"Chung","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2024.09.007_bib0017","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.2147\/IJN.S431409","article-title":"Nanotechnology-based drug delivery systems for honokiol: enhancing therapeutic potential and overcoming limitations","volume":"18","author":"Yang","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.disamonth.2006.05.005","article-title":"Oxidative stress and antioxidants in inflammatory bowel disease","volume":"52","author":"Karp","year":"2006","journal-title":"Dis. Mon."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/physrev.00040.2012","article-title":"Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases","volume":"94","author":"Bhattacharyya","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.actbio.2024.09.007_bib0020","first-page":"1335","article-title":"Oxidative stress and inflammatory bowel disease","volume":"4","author":"Almenier","year":"2012"},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0021","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00054725-199712000-00003","article-title":"The role of reactive oxygen metabolites in ulcerative colitis","volume":"3","author":"Dagli","year":"1997","journal-title":"Inflamm. Bowel. Dis."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrgastro.2010.66","article-title":"IBD: selective nanoparticle adhesion can enhance colitis therapy","volume":"7","author":"Lamprecht","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0023","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0024","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/cc2900","article-title":"Science review: extracellular acidosis and the immune response: clinical and physiologic implications","volume":"8","author":"Kellum","year":"2004","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.actbio.2024.09.007_bib0025","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the intellicap\u24c7 system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0026","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/156720112803529774","article-title":"Anatomical, biochemical and physiological considerations of the colon in design and development of novel drug delivery systems","volume":"9","author":"Vadlamudi","year":"2012","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0027","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","article-title":"Gut instincts: explorations in intestinal physiology and drug delivery","volume":"364","author":"McConnell","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2024.09.007_bib0028","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32607\/20758251-2018-10-4-33-48","article-title":"Bacterial enzymes and antibiotic resistance","volume":"10","author":"Egorov","year":"2018","journal-title":"Acta Nat."},{"key":"10.1016\/j.actbio.2024.09.007_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.09.008","article-title":"Bioresponsive drug delivery systems for the treatment of inflammatory diseases","volume":"327","author":"Dou","year":"2020","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2024.09.007_bib0031","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.actbio.2024.09.007_bib0032","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1021\/acsnano.3c06019","article-title":"Stimuli-responsive polymer-based nanosystems for cancer theranostics","volume":"17","author":"Wei","year":"2023","journal-title":"ACS. Nano"},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0033","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"issue":"23","key":"10.1016\/j.actbio.2024.09.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101618","article-title":"Construction of pH-dependent nanozymes with oxygen vacancies as the high-efficient reactive oxygen species scavenger for oral-administrated anti-inflammatory therapy","volume":"10","author":"Zhao","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"19","key":"10.1016\/j.actbio.2024.09.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300601","article-title":"A curcumin-modified coordination polymers with ROS scavenging and macrophage phenotype regulating properties for efficient ulcerative colitis treatment","volume":"10","author":"Yao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2024.09.007_bib0036","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2019.02.011","article-title":"Alginate\/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model","volume":"137","author":"Cao","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2024.09.007_bib0037","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/IJN.S347506","article-title":"Oral delivery of pterostilbene by L-Arginine-mediated \"Nano-Bomb\" carrier for the treatment of ulcerative colitis","volume":"17","author":"Wei","year":"2022","journal-title":"Int. J. Nano"},{"issue":"15","key":"10.1016\/j.actbio.2024.09.007_bib0038","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2217\/nnm-2018-0415","article-title":"Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease","volume":"14","author":"Zeeshan","year":"2019","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0039","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/acsnano.2c11188","article-title":"Synthetic lignin-derived therapeutic nano reagent as intestinal pH-sensitive drug carriers capable of bypassing the gastric acid environment for colitis treatment","volume":"17","author":"Zhao","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2024.09.007_bib0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biomaterials.2018.09.024","article-title":"Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine","volume":"185","author":"Li","year":"2018","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0041","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/acsami.1c21700","article-title":"Biomimetic MOF nanoparticles delivery of C-Dot nanozyme and CRISPR\/Cas9 system for site-specific treatment of ulcerative colitis","volume":"14","author":"Ma","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2024.09.007_bib0042","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2019.10.054","article-title":"A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease","volume":"316","author":"Li","year":"2019","journal-title":"J. Control Rel."},{"issue":"34","key":"10.1016\/j.actbio.2024.09.007_bib0043","doi-asserted-by":"crossref","first-page":"40249","DOI":"10.1021\/acsami.1c09215","article-title":"Genistein-derived ROS-responsive nanoparticles relieve colitis by regulating mucosal homeostasis","volume":"13","author":"Fan","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"18","key":"10.1016\/j.actbio.2024.09.007_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900610","article-title":"A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000973","article-title":"Mesopore to macropore transformation of metal-organic framework for drug delivery in inflammatory bowel disease","volume":"10","author":"Yin","year":"2021","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.actbio.2024.09.007_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119252","article-title":"Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease","volume":"285","author":"Huang","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"50","key":"10.1016\/j.actbio.2024.09.007_bib0047","doi-asserted-by":"crossref","first-page":"eabj0624","DOI":"10.1126\/sciadv.abj0624","article-title":"Genome-editing prodrug: targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease","volume":"7","author":"Yan","year":"2021","journal-title":"Sci. Adv."},{"issue":"28","key":"10.1016\/j.actbio.2024.09.007_bib0048","doi-asserted-by":"crossref","first-page":"15348","DOI":"10.1039\/D0NR03037F","article-title":"Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota","volume":"12","author":"Cheng","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12951-023-01889-0","article-title":"Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121884","article-title":"Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy","volume":"623","author":"Xu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0051","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/10717544.2021.1934189","article-title":"An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2024.09.007_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115613","article-title":"Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis","volume":"230","author":"Chen","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"26","key":"10.1016\/j.actbio.2024.09.007_bib0053","doi-asserted-by":"crossref","first-page":"31214","DOI":"10.1021\/acsami.3c04408","article-title":"Reductase-Labile peptidic supramolecular hydrogels aided in oral delivery of probiotics","volume":"15","author":"Chen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2024.09.007_bib0054","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.carbpol.2017.12.021","article-title":"Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases","volume":"189","author":"Sun","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"22","key":"10.1016\/j.actbio.2024.09.007_bib0055","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1021\/acsami.3c02128","article-title":"Colon-targeting angelica sinensis polysaccharide nanoparticles with dual responsiveness for alleviation of ulcerative colitis","volume":"15","author":"Xu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0056","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acsami.1c21595","article-title":"Multistage-responsive nanocomplexes attenuate ulcerative colitis by improving the accumulation and distribution of oral nucleic acid drugs in the colon","volume":"14","author":"Li","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2024.09.007_bib0057","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2019.04.011","article-title":"Thermoreversible mucoadhesive polymer-drug dispersion for sustained local delivery of budesonide to treat inflammatory disorders of the GI tract","volume":"303","author":"Antonino","year":"2019","journal-title":"J. Control Rel."},{"issue":"28","key":"10.1016\/j.actbio.2024.09.007_bib0058","doi-asserted-by":"crossref","first-page":"33273","DOI":"10.1021\/acsami.3c03332","article-title":"Mn3O4 nanozyme loaded thermosensitive PDLLA-PEG-PDLLA hydrogels for the treatment of inflammatory bowel disease","volume":"15","author":"Yang","year":"2023","journal-title":"ACS Appl. Mater. Int."},{"key":"10.1016\/j.actbio.2024.09.007_bib0059","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","article-title":"Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease","volume":"558","author":"Zeeshan","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.48.4.571","article-title":"Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs","volume":"48","author":"Nugent","year":"2001","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.actbio.2024.09.007_bib0061","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1002\/anie.201912182","article-title":"An enzyme-mimicking single-atom catalyst as an efficient multiple reactive oxygen and nitrogen species scavenger for sepsis management","volume":"59","author":"Cao","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0062","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/nn300291r","article-title":"Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity","volume":"6","author":"Chen","year":"2012","journal-title":"ACS Nano"},{"issue":"31","key":"10.1016\/j.actbio.2024.09.007_bib0063","doi-asserted-by":"crossref","first-page":"26108","DOI":"10.1021\/acsami.8b10345","article-title":"Prussian blue nanozyme with multienzyme activity reduces colitis in mice","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"29","key":"10.1016\/j.actbio.2024.09.007_bib0064","doi-asserted-by":"crossref","first-page":"eabb2695","DOI":"10.1126\/sciadv.abb2695","article-title":"Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-023-02288-z","article-title":"Modulation of autophagy and apoptosis can contribute to the anticancer effect of Abemaciclib\/Celecoxib combination in colon cancer cells","volume":"41","author":"Alian","year":"2024","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.actbio.2024.09.007_bib0066","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"22","key":"10.1016\/j.actbio.2024.09.007_bib0067","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.actbio.2024.09.007_bib0068","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1039\/C9SC05506A","article-title":"A H2O2 self-sufficient nanoplatform with domino effects for thermal-responsive enhanced chemodynamic therapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0069","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1021\/acsnano.9b07898","article-title":"Full-process radiosensitization based on nanoscale metal-organic frameworks","volume":"14","author":"Gong","year":"2020","journal-title":"ACS Nano"},{"issue":"39","key":"10.1016\/j.actbio.2024.09.007_bib0070","doi-asserted-by":"crossref","first-page":"16723","DOI":"10.1021\/jacs.0c07206","article-title":"Regulating photocatalysis by spin-state manipulation of cobalt in covalent organic frameworks","volume":"142","author":"Gong","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0071","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.154.5.2434","article-title":"Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation","volume":"154","author":"Casini-Raggi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0072","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2012.00315","article-title":"IL-1 family cytokines trigger sterile inflammatory disease","volume":"3","author":"Lukens","year":"2012","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0073","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.MIB.0000437616.37000.41","article-title":"Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?","volume":"20","author":"McLean","year":"2014","journal-title":"Inflamm. Bowel. Dis."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0074","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12307-015-0177-7","article-title":"IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer","volume":"8","author":"Voronov","year":"2015","journal-title":"Cancer Microenviron."},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0075","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/cyto.1998.0355","article-title":"Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice","volume":"10","author":"Arai","year":"1998","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0076","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00296-011-2096-3","article-title":"Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations","volume":"32","author":"Kaiser","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0077","first-page":"415","article-title":"Therapeutic effects of glycyrrhizic acid","volume":"8","author":"Ming","year":"2013","journal-title":"Nat. Prod. Commun."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0078","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/taap.1999.8843","article-title":"Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling","volume":"162","author":"Ploeger","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"10.1016\/j.actbio.2024.09.007_bib0079","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0960327112446843","article-title":"Licorice induced hypokalemia, edema, and thrombocytopenia","volume":"31","author":"Celik","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1104\/pp.110.155119","article-title":"Lignin biosynthesis and structure","volume":"153","author":"Vanholme","year":"2010","journal-title":"Plant Physiol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0081","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.copbio.2019.02.018","article-title":"Lignin biosynthesis and its integration into metabolism","volume":"56","author":"Vanholme","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0082","first-page":"71","article-title":"How far is Lignin from being a biomedical material?","volume":"8","author":"Sugiarto","year":"2022","journal-title":"Bio Mater."},{"issue":"1-2","key":"10.1016\/j.actbio.2024.09.007_bib0083","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/B:PHYT.0000047809.65444.a4","article-title":"Lignins: natural polymers from oxidative coupling of 4-hydroxyphenyl-propanoids","volume":"3","author":"Ralph","year":"2004","journal-title":"Phytochem. Rev."},{"issue":"6185","key":"10.1016\/j.actbio.2024.09.007_bib0084","doi-asserted-by":"crossref","DOI":"10.1126\/science.1246843","article-title":"Lignin valorization: improving lignin processing in the biorefinery","volume":"344","author":"Ragauskas","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.actbio.2024.09.007_bib0085","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cej.2017.07.022","article-title":"pH-responsive lignin-based complex micelles: preparation, characterization and application in oral drug delivery","volume":"327","author":"Li","year":"2017","journal-title":"Chem. Eng. J."},{"issue":"10","key":"10.1016\/j.actbio.2024.09.007_bib0086","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/anie.201913700","article-title":"Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment","volume":"59","author":"Wu","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0087","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tips.2015.02.001","article-title":"Novel therapeutic targets in rheumatoid arthritis","volume":"36","author":"Koenders","year":"2015","journal-title":"Trends. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0088","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12951-018-0403-9","article-title":"Recent advancements in the use of exosomes as drug delivery systems","volume":"16","author":"Bunggulawa","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0089","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2024.09.007_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control Rel."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0091","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2014.01.144","article-title":"CD98hc regulates the development of experimental colitis by controlling effector and regulatory CD4+ T cells","volume":"444","author":"Bhuyan","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0092","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1172\/JCI44631","article-title":"CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice","volume":"121","author":"Nguyen","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0093","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.01388-12","article-title":"Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens","volume":"81","author":"Charania","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0094","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.1038\/s41598-018-34474-9","article-title":"Overexpression of CD98 in intestinal epithelium dysregulates miRNAs and their targeted proteins along the ileal villus-crypt axis","volume":"8","author":"Han","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/C8CS00457A","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)","volume":"48","author":"Wu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"45","key":"10.1016\/j.actbio.2024.09.007_bib0096","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805368","article-title":"Recent advances in nanozyme research","volume":"31","author":"Wang","year":"2019","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.actbio.2024.09.007_bib0097","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2217\/nnm-2017-0196","article-title":"Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis","volume":"12","author":"Zhang","year":"2017","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.actbio.2024.09.007_bib0098","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2024.09.007_bib0099","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12934-015-0198-4","article-title":"Serine protease inhibitors protect better than IL-10 and TGF-\u03b2 anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci","volume":"14","author":"Berm\u00fadez-Humar\u00e1n","year":"2015","journal-title":"Microb. Cell Fact."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4161\/hv.28549","article-title":"Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation","volume":"10","author":"Mart\u00edn","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7351","key":"10.1016\/j.actbio.2024.09.007_bib0101","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/17425247.2016.1166203","article-title":"Micro\/nano-particulate drug delivery systems: a boon for the treatment of inflammatory bowel disease","volume":"13","author":"Patel","year":"2016","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2024.09.007_bib0103","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.smim.2017.08.010","article-title":"Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases","volume":"34","author":"Prosperi","year":"2017","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0104","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species","volume":"44","author":"He","year":"2017","journal-title":"Cell Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0105","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bph.13828","article-title":"Reactive oxygen species: key regulators in vascular health and diseases","volume":"175","author":"Chen","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"41","key":"10.1016\/j.actbio.2024.09.007_bib0106","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3748\/wjg.v24.i41.4622","article-title":"Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets","volume":"24","author":"Nanini","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.actbio.2024.09.007_bib0107","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/ebm.2011.011358","article-title":"Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence","volume":"237","author":"Zhu","year":"2012","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0108","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2012-303955","article-title":"Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation","volume":"62","author":"Cader","year":"2013","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.actbio.2024.09.007_bib0109","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/BF02093613","article-title":"Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease","volume":"41","author":"Lih-Brody","year":"1996","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0016-5085(92)91112-H","article-title":"Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease","volume":"103","author":"Simmonds","year":"1992","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0111","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3109\/10715762.2012.717692","article-title":"Oxidative stress in ulcerative colitis: an old concept but a new concern","volume":"46","author":"Jena","year":"2012","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2024.09.007_bib0113","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jconrel.2015.09.056","article-title":"One-component nanomedicine","volume":"219","author":"Su","year":"2015","journal-title":"J. Control Rel."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/wnan.1364","article-title":"Polymeric nanoparticles: the future of nanomedicine","volume":"8","author":"Banik","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"15","key":"10.1016\/j.actbio.2024.09.007_bib0115","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.addr.2013.08.005","article-title":"Carbon nanotubes for delivery of small molecule drugs","volume":"65","author":"Wong","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0116","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.etap.2012.07.011","article-title":"Recent advances in benefits and hazards of engineered nanoparticles","volume":"34","author":"Radad","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.addr.2007.11.007","article-title":"Clinical toxicities of nanocarrier systems","volume":"60","author":"Vega-Villa","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2024.09.007_bib0118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2016.06.013","article-title":"Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering","volume":"110-111","author":"Eskandari","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.actbio.2024.09.007_bib0119","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/ar4003009","article-title":"Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics","volume":"47","author":"Gu","year":"2014","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0120","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.3390\/ijms21113956","article-title":"Natural product-based nanomedicine in treatment of inflammatory bowel disease","volume":"21","author":"Khare","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0121","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.3390\/molecules18067253","article-title":"Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease","volume":"18","author":"Debnath","year":"2013","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0122","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/foods9111604","article-title":"Synthesis, characterization, and evaluation of genistein-loaded zein\/carboxymethyl chitosan nanoparticles with improved water dispersibility, enhanced antioxidant activity, and controlled release property","volume":"9","author":"Xiao","year":"2020","journal-title":"Foods"},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0123","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0124","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"277","key":"10.1016\/j.actbio.2024.09.007_bib0126","first-page":"277er2","article-title":"Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice","volume":"7","author":"Fredman","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.actbio.2024.09.007_bib0127","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.1303377110","article-title":"Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles","volume":"110","author":"Kamaly","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actbio.2024.09.007_bib0128","article-title":"Local delivery of macromolecules to treat diseases associated with the colon","volume":"136\u2013137","author":"Bak","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0129","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1039\/D0RA09878G","article-title":"Recent advances in nanosized metal organic frameworks for drug delivery and tumor therapy","volume":"11","author":"Yang","year":"2021","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0130","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1021\/acsami.0c21486","article-title":"Iron-based metal-organic frameworks in drug delivery and biomedicine","volume":"13","author":"Liu","year":"2021","journal-title":"ACS Appl. Mater. Int."},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0131","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/mp9000926","article-title":"Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa","volume":"6","author":"Tirosh","year":"2009","journal-title":"Mol. Pharm."},{"issue":"6502","key":"10.1016\/j.actbio.2024.09.007_bib0132","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aaz9906","article-title":"The activities of drug inactive ingredients on biological targets","volume":"369","author":"Pottel","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0133","first-page":"43","article-title":"Bionic natural small molecule co-assemblies towards targeted and synergistic Chemo\/PDT\/CDT","volume":"27","author":"Fu","year":"2023","journal-title":"Bio Res."},{"key":"10.1016\/j.actbio.2024.09.007_bib0134","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.2147\/IJN.S436940","article-title":"Cell membrane coated pH-responsive intelligent bionic delivery nanoplatform for active targeting in photothermal therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.actbio.2024.09.007_bib0135","doi-asserted-by":"crossref","first-page":"eabe2888","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: A transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","volume":"7","author":"Wan","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.actbio.2024.09.007_bib0136","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS. Nano"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0137","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.actbio.2024.09.007_bib0138","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV-CRISPR-Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.actbio.2024.09.007_bib0139","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nantod.2017.08.006","article-title":"Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.actbio.2024.09.007_bib0140","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0141","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/aem.44.6.1428-1434.1982","article-title":"Cellulolytic and non-cellulolytic bacteria in rat gastrointestinal tracts","volume":"44","author":"Macy","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0142","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.carbpol.2018.06.107","article-title":"Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan\/alginate\/Eudragit S multilayers for the treatment of inflammatory bowel disease","volume":"198","author":"Oshi","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2024.09.007_bib0143","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNF\u03b1 gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J. Control Rel."},{"issue":"26","key":"10.1016\/j.actbio.2024.09.007_bib0144","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1056\/NEJMc1803103","article-title":"Fecal microbiota transplantation for primary clostridium difficile infection","volume":"378","author":"Juul","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.actbio.2024.09.007_bib0145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41575-019-0199-6","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"34","key":"10.1016\/j.actbio.2024.09.007_bib0146","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002406","article-title":"On-demand bacterial reactivation by restraining within a triggerable nanocoating","volume":"32","author":"Feng","year":"2020","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.actbio.2024.09.007_bib0147","doi-asserted-by":"crossref","first-page":"eabb1952","DOI":"10.1126\/sciadv.abb1952","article-title":"Bioinspired oral delivery of gut microbiota by self-coating with biofilms","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.actbio.2024.09.007_bib0148","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsps.2020.01.004","article-title":"Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery","volume":"28","author":"Alsehli","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.actbio.2024.09.007_bib0149","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.carbpol.2017.12.009","article-title":"Biological activities and pharmaceutical applications of polysaccharide from natural resources: a review","volume":"183","author":"Yu","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2024.09.007_bib0150","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ijbiomac.2021.05.213","article-title":"Extraction, structure, pharmacological activities and drug carrier applications of Angelica sinensis polysaccharide","volume":"183","author":"Nai","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0151","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/jmf.2019.4607","article-title":"Inhibition of dextran sodium sulfate-induced experimental colitis in mice by angelica sinensis polysaccharide","volume":"23","author":"Cheng","year":"2020","journal-title":"J. Med. Food"},{"key":"10.1016\/j.actbio.2024.09.007_bib0152","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.omtn.2021.06.003","article-title":"The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease","volume":"25","author":"Zou","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.actbio.2024.09.007_bib0153","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.omtn.2021.01.024","article-title":"Targeting the epigenome in in-stent restenosis: from mechanisms to therapy","volume":"23","author":"Yang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"13","key":"10.1016\/j.actbio.2024.09.007_bib0154","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.7150\/ijbs.62506","article-title":"Targeting non-coding RNAs in unstable atherosclerotic plaques: mechanism, regulation, possibilities, and limitations","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.actbio.2024.09.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102089","article-title":"Role of acetylation in doxorubicin-induced cardiotoxicity","volume":"46","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.actbio.2024.09.007_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112154","article-title":"Nicotine: regulatory roles and mechanisms in atherosclerosis progression","volume":"151","author":"Fu","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.actbio.2024.09.007_bib0157","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.ASW.0000522161.13573.62","article-title":"Relative temperature maximum in wound infection and inflammation as compared with a control subject using long-wave infrared thermography","volume":"30","author":"Chanmugam","year":"2017","journal-title":"Adv. Skin Wound Care"},{"issue":"6","key":"10.1016\/j.actbio.2024.09.007_bib0158","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"36","key":"10.1016\/j.actbio.2024.09.007_bib0159","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.biomaterials.2009.08.058","article-title":"Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering","volume":"30","author":"Tan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.09.007_bib0160","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1038\/srep19077","article-title":"Synthesis, characterization, and application of reversible PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2024.09.007_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120605","article-title":"Well-dispersed platelet lysate entrapped nanoparticSles incorporate with injectable PDLLA-PEG-PDLLA triblock for preferable cartilage engineering application","volume":"268","author":"Tang","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2024.09.007_bib0162","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1272\/jnms.JNMS.2021_88-505","article-title":"Efficacy of a deep thermal therapy system for osteoarthritis of the knee","volume":"88","author":"Harada","year":"2021","journal-title":"J. Nippon Med. Sch."},{"issue":"9","key":"10.1016\/j.actbio.2024.09.007_bib0163","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004793","article-title":"DNA-grafted hyaluronic acid system with enhanced injectability and biostability for photo-controlled osteoarthritis gene therapy","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.actbio.2024.09.007_bib0164","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004128","article-title":"Platelet-mimicking therapeutic system for noninvasive mitigation of the progression of atherosclerotic plaques","volume":"8","author":"Ma","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2024.09.007_bib0165","first-page":"18","article-title":"Black TiO2 nanoprobe-mediated mild phototherapy reduces intracellular lipid levels in atherosclerotic foam cells via cholSesterol regulation pathways instead of apoptosis","volume":"17","author":"Dai","year":"2022","journal-title":"Bio Mater."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:25:43Z","timestamp":1778624743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706124005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":165,"alternative-id":["S1742706124005233"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2024.09.007","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acta Materialia Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}